Each week we highlight five things affecting the life sciences industry. Here's the latest. Small biopharma companies drive 2024 drug approvals Small companies led the way with 55 new drug and biologic approvals, reflecting a trend of biotechs resisting buyouts and opting to market their products ... READ MORE >
M&A
Consumer products M&A insights from the third quarter
Based on information available as of Oct. 23, 2022 from PitchBook Data, Inc., consumer products closed deal activity continued to slow, contracting for the third consecutive quarter. Current economic challenges, including inflationary pressures and the resulting shift in consumer discretionary spending, ... READ MORE >